Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections.

Genotyping methods for Plasmodium falciparum drug efficacy trials have not been standardized and may fail to accurately distinguish recrudescence from new infection, especially in high transmission areas where polyclonal infections are common. We developed a simple method for genotyping using previously identified microsatellites and capillary electrophoresis, validated this method using mixtures of laboratory clones, and applied the method to field samples. Two microsatellite markers produced accurate results for single-clone but not polyclonal samples. Four other microsatellite markers were as sensitive as, and more specific than, commonly used genotyping techniques based on merozoite surface proteins 1 and 2. When applied to samples from 15 patients in Burkina Faso with recurrent parasitemia after treatment with sulphadoxine-pyrimethamine, the addition of these four microsatellite markers to msp1 and msp2 genotyping resulted in a reclassification of outcomes that strengthened the association between dhfr 59R, an anti-folate resistance mutation, and recrudescence (P = 0.31 versus P = 0.03). Four microsatellite markers performed well on polyclonal samples and may provide a valuable addition to genotyping for clinical drug efficacy studies in high transmission areas.

[1]  J. T. Williams,et al.  Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. , 2000, Molecular biology and evolution.

[2]  Fengzhu Sun,et al.  Taq DNA polymerase slippage mutation rates measured by PCR and quasi-likelihood analysis: (CA/GT)n and (A/T)n microsatellites. , 2003, Nucleic acids research.

[3]  O. Doumbo,et al.  Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. , 1995, The American journal of tropical medicine and hygiene.

[4]  J. Jensen.  In vitro culture of Plasmodium parasites. , 2002, Methods in molecular medicine.

[5]  P. Rosenthal,et al.  Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. , 2005, The American journal of tropical medicine and hygiene.

[6]  J. Carpten,et al.  Modulation of non-templated nucleotide addition by Taq DNA polymerase: primer modifications that facilitate genotyping. , 1996, BioTechniques.

[7]  W. Jarra,et al.  Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  A. Hubbard,et al.  Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. , 2003, The American journal of tropical medicine and hygiene.

[9]  C. Rogier,et al.  No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. , 1998, The American journal of tropical medicine and hygiene.

[10]  X. Su,et al.  Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples , 1999, Parasitology.

[11]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[12]  J. Le bras,et al.  Plasmodium falciparum clonal population dynamics during malaria treatment. , 2004, The Journal of infectious diseases.

[13]  C. Musonda,et al.  Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts. , 2004, Bioorganic & medicinal chemistry letters.

[14]  X. Su,et al.  Toward a high-resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats. , 1996, Genomics.

[15]  L. Ranford-Cartwright,et al.  Comparison of microsatellite and antigen-coding loci for differentiating recrudescing Plasmodium falciparum infections from reinfections in Kenya. , 2006, International journal for parasitology.

[16]  U. d’Alessandro,et al.  Plasmodium falciparum genotyping by microsatellites as a method to distinguish between recrudescent and new infections. , 2005, The American journal of tropical medicine and hygiene.

[17]  G. Snounou,et al.  The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. , 1998, Parasitology today.

[18]  M. Polz,et al.  Heteroduplexes in mixed-template amplifications: formation, consequence and elimination by 'reconditioning PCR'. , 2002, Nucleic acids research.

[19]  L. Ranford-Cartwright,et al.  In vitro recombination during PCR of Plasmodium falciparum DNA: a potential pitfall in molecular population genetic analysis. , 2002, Molecular and biochemical parasitology.

[20]  J. M. Rubio,et al.  Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[21]  P. Rosenthal,et al.  Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy. , 2005, The American journal of tropical medicine and hygiene.

[22]  M. Duraisingh,et al.  Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. , 1998, Experimental parasitology.

[23]  R Higuchi,et al.  Preferential PCR amplification of alleles: mechanisms and solutions. , 1992, PCR methods and applications.